Chris Waddell, a medtech executive focused on various structural heart technologies, is leaving Abbott after several years to "recharge" and pursue a new opportunity.

Executives from two of the world’s largest medtech companies, Medtronic and Boston Scientific, are among the leaders calling for "state, local and federal officials to work together to find real solutions."

Julie Szeker, the publicly traded company’s chief legal officer and corporate secretary, submitted her resignation on Jan. 12, according to an SEC filing.

CMS is considering substantial updates to its TAVR policies, including coverage for asymptomatic patients. Some stakeholders are excited, embracing the possibility of expanded indications and fewer restrictions. Others are concerned that the changes would be too much, too soon.

Where have the missing rural American hospitals gone? And where is rural healthcare headed? The discussion is on in Washington and elsewhere.  

Diagnostic Radiology & Imaging—formerly Greensboro Imaging—has selected former Raleigh Radiology CEO Frank Manole, DNP, MBA, to fill the key role.  

Jocelyn Rapelyea, MD, completed her residency at the D.C. institution and rose to the rank of professor after years there. 

A new comprehensive report detailed the latest stats and trends in hypertension, coronary heart disease, stroke and many other areas of interest. “Progress in cardiovascular health depends on knowing where we stand,” the authors wrote. “To improve, we must measure—not occasionally, but consistently, transparently and with purpose.”